By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arsanis, Inc. 

16 Cavendish Court

Lebanon  New Hampshire  03766  U.S.A.
Phone: 603-727-7107 Fax: n/a



Company News
Arsanis Presents Preclinical Data On Lead Product Candidate, ASN100, At The “2017 ASM/ESCMID Conference On Drug Development To Meet The Challenge Of Antimicrobial Resistance” 9/8/2017 6:41:32 AM
Arsanis Scores $45.5 Million to Advance Infectious Disease Pipeline 4/26/2017 8:14:31 AM
Arsanis And Adimab LLC. Enter Into License Agreement To Target Respiratory Syncytial Virus (RSV) With Monoclonal Antibodies 2/27/2017 7:40:16 AM
Arsanis Release: Biopharma Announces First Patient Dosed In Global Phase 2 Study Of ASN100 For Prevention Of Staphylococcus Aureus Pneumonia 1/24/2017 7:53:13 AM
Arsanis Receives FDA Fast Track Designation For ASN100 For The Prevention Of Staphylococcus Aureus Pneumonia 12/1/2016 8:02:04 AM
Arsanis Announces Two Key Publications Supporting Its Lead Program ASN100 9/6/2016 11:18:05 AM
Arsanis Presents Data At ASM Microbe 2016 Demonstrating Protection Against Multidrug-Resistant Escherichia Coli And Klebsiella Pneumoniae Using Monoclonal Antibody Technology 6/17/2016 10:39:40 AM
Arsanis Appoints Chris Stevens, MD, As Chief Medical Officer 6/2/2016 10:25:58 AM
Arsanis To Present At The Jefferies 2016 Healthcare Conference 5/31/2016 10:45:34 AM
Massachusetts' Arsanis Names a New CEO 5/9/2016 6:10:19 AM